Stromedix
Latest round
- Series B
Last raised
- Mar 2008
Total raised
- $30M
Investors
- 5
About Stromedix
Founded in 2005 and is based in Cambridge, Massachusetts, Stromedix is a clinical-stage biotechnology company, develops drugs to treat fibrotic organ failure. It offers STX-100, a humanized monoclonal antibody that provides anti-fibrotic activity in preclinical models of lung, kidney, and liver diseases.
Who invested in Stromedix
5 investors across 3 rounds
See all investors in Stromedix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stromedix
Who invested in Stromedix?
Stromedix has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stromedix raised?
Stromedix has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Stromedix last raise money?
Stromedix's most recent round on record is a Series B, in Mar 2008.
What does Stromedix do?
Founded in 2005 and is based in Cambridge, Massachusetts, Stromedix is a clinical-stage biotechnology company, develops drugs to treat fibrotic organ failure.
Where is Stromedix headquartered?
Stromedix is headquartered in Cambridge, US.
Which VCs invest in companies like Stromedix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Stromedix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Stromedix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.